Login to Your Account



FDA Kidney Panel Votes On ESAs

ImClone, Amgen Headlines Turn Eyes To Cancer Drugs

By Randall Osborne


Monday, September 17, 2007
No Abstract

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription